0
Skip to Content
Wesana Health
Current Page: Team
Newsroom
Contact
Investors
Wesana Health
Current Page: Team
Newsroom
Contact
Current Page: Team
Newsroom
Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Stock Information
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Governance
    • Board of Directors
    • Governance Documents
  • SEDAR
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 21, 2023 9:00am EDT

Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery

Dec 16, 2022 5:00pm EST

Wesana Health Announces Receipt of Short-Term Loan

Sep 01, 2022 7:14pm EDT

Wesana Announces Sale of Clinic Management Services Organization

Aug 29, 2022 8:00pm EDT

Wesana Announces Second Quarter 2022 Financial Results

Jun 08, 2022 9:46am EDT

Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

May 31, 2022 5:30pm EDT

Wesana Announces First Quarter 2022 Financial Results

May 10, 2022 7:30am EDT

Wesana Health Outlines Accelerated Drug Development Pathway

May 05, 2022 9:08am EDT

Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and Other Care Delivery Assets

May 02, 2022 10:44pm EDT

Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highlights

Apr 18, 2022 6:34pm EDT

Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder

  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
RSS
  • email Email Alerts
  • location_city Company Profile
  • perm_contact_calendar Contacts
  • rss_feed RSS News Feed

© Wesana Health